Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | APEX1 | P27695 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ioglicic Acid SCHEMBL29699760 | 1.00 | LMNA (0.55) | LMNASMN1; SMN2TSHRMAPK1APEX1 | |
| SCHEMBL11697050 | 0.97 | LMNA (0.52) | LMNASMN1; SMN2TSHRMAPK1 | |
| SCHEMBL11694594 | 0.88 | LMNA (0.41) | LMNASMN1; SMN2TSHRMAPK1 | |
| SCHEMBL11700573 | 0.87 | LMNA (0.58) | LMNASMN1; SMN2TSHRMAPK1APEX1 | |
| SCHEMBL11694130 | 0.86 | LMNA (0.52) | LMNASMN1; SMN2TSHRMAPK1 | |
| SCHEMBL11775063 | 0.85 | LMNA (0.51) | LMNASMN1; SMN2TSHRMAPK1 | |
| SCHEMBL11775071 | 0.85 | LMNA (0.51) | LMNASMN1; SMN2TSHRMAPK1 | |
| SCHEMBL11695398 | 0.84 | LMNA (0.56) | LMNASMN1; SMN2TSHRMAPK1APEX1 | |
| SCHEMBL11695859 | 0.84 | LMNA (0.48) | LMNASMN1; SMN2TSHRMAPK1ALDH1A1 | |
| SCHEMBL11696569 | 0.84 | LMNA (0.43) | LMNASMN1; SMN2APEX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 450 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4683579-A1 | RELIEVE BACK PAIN AND/OR REBUILDING INTERVERTERAL DISC | Yeung, Jeffrey E. (US) | 2026-01-28 | — | — | EP | claimed |
| US-20250369011-A1 | INSULIN PROMOTER FOR GENE THERAPY FOR TYPE 2 DIABETES MELLITUS | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2025-12-04 | — | — | US | claimed |
| US-20250066444-A1 | GLUCAGON PROMOTER FOR DIABETES GENE THERAPY | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2025-02-27 | — | — | US | claimed |
| WO-2024158529-A1 | RELIEVE BACK PAIN AND/OR REBUILDING INTERVERTERAL DISC | YEUNG JEFFREY E (US) | 2024-08-02 | — | — | WO | claimed |
| WO-2021238893-A1 | EFFICIENT AND EFFECTIVE TISSUE CLEARING AGENTS AND THEIR COMPOSITIONS | THE CHINESE UNIVERSITY OF HONG KONG (CN) | 2021-12-02 | — | — | WO | claimed |
| US-20160375234-A1 | TRANSPAPILLARY METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING BREAST CONDITIONS | ATOSSA THERAPEUTICS, INC. | 2016-12-29 | — | — | US | claimed |
| EP-3092027-A1 | TRANSPAPILLARY METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING BREAST CONDITIONS | Atossa Genetics Inc. (US) | 2016-11-16 | — | — | EP | claimed |
| US-9393325-B2 | Bioabsorbable co-filler for cerebrovascular aneurysms | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2016-07-19 | — | — | US | claimed |
| US-20160151124-A1 | IMPLANTABLE MARKERS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2016-06-02 | — | — | US | claimed |
| EP-3019208-A1 | IMPLANTABLE MARKERS | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. (IL) | 2016-05-18 | — | — | EP | claimed |
| CN-101141976-A | Local treatment of bone defects with matrices releasing BMP or PTH | KUROS BIOSURGERY AG (CH) | 2008-03-12 | — | — | CN | claimed |
| EP-1830902-A2 | COMBINATION COMPRISING AN AGENT PROVIDING A SIGNAL, AN IMPLANT MATERIAL AND A DRUG | CINVENTION AG (DE) | 2007-09-12 | — | — | EP | claimed |
| WO-2007061529-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | SCIDOSE LLC. (US) | 2007-05-31 | — | — | WO | claimed |
| US-20070116729-A1 | Lyophilization process and products obtained thereby | SCIDOSE LLC | 2007-05-24 | — | — | US | claimed |
| US-20060177379-A1 | Composition comprising an agent providing a signal, an implant material and a drug | CINVENTION AG (DE) | 2006-08-10 | — | — | US | claimed |
| WO-2006069677-A2 | COMBINATION COMPRISING AN AGENT PROVIDING A SIGNAL, AN IMPLANT MATERIAL AND A DRUG | CINVENTION AG (DE) | 2006-07-06 | — | — | WO | claimed |
| US-20060024365-A1 | Novel dosage form | VAYA NAVIN | 2006-02-02 | — | — | US | claimed |
| US-20060018933-A1 | Novel drug delivery system | TORRENT PHARMACEUTICALS LIMITED (IN) | 2006-01-26 | — | — | US | claimed |
| US-20060018934-A1 | Novel drug delivery system | TORRENT PHARMACEUTICALS LIMITED (IN) | 2006-01-26 | — | — | US | claimed |
| US-3953501-A | X-RAY CONTRAST AGENTS | SCHERING AKTIENGESELLSCHAFT (DT) | 1976-04-27 | — | — | US | claimed |